Intraportal transplantation of human bone marrow mesenchymal stem cells in pigs with fulminant hepatic failure

Hepatology

Volumn 57, Issue 5, 2013, Pages 2088-2088

  Jitraruch, Suttiruk ^a   Mitry, Ragai R ^a   Dhawan, Anil ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER;

BONE MARROW; FULMINANT HEPATIC FAILURE; GRAFT RECIPIENT; IMMUNE RESPONSE; LETTER; LIVER CELL; LONG TERM SURVIVAL; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SWINE DISEASE;

ANIMALS; HUMANS; LIVER FAILURE, ACUTE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION;

EID: 84876741168     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25971     Document Type: Letter

References (4)

1. Li J, Zhang L, Xin J, Jiang L, Li J, Zhang T, et al. Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. HEPATOLOGY 2012; doi: 10.1002/hep.25722.
2. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890-896.
3. Le Blanc K, Ringdén O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007; 262: 509-525.
4. Grinnemo KH, Månsson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J Thorac Cardiovasc Surg 2004; 127: 1293-1300.